Literature DB >> 17135603

Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.

Carine Chavey1, Jérémie Boucher, Marie-Noëlle Monthouël-Kartmann, E Helene Sage, Isabelle Castan-Laurell, Philippe Valet, Sophie Tartare-Deckert, Emmanuel Van Obberghen.   

Abstract

OBJECTIVE: To explore the regulation of secreted protein acidic and rich in cysteine (SPARC) expression and its role in adipose tissue. RESEARCH METHODS AND PROCEDURES: We studied the regulation of SPARC expression in transgenic mice expressing the human beta3 and alpha2 adrenergic receptors on a murine beta3 adrenergic receptor null background that became obese under a high-fat diet mainly as a result of adipose tissue hyperplasia. Furthermore, we analyzed its expression in human adipose tissue and its regulation during adipocyte differentiation.
RESULTS: SPARC protein in adipose tissue was increased in obese transgenic mice compared with control mice, indicating that SPARC expression was associated with adipose tissue hyperplasia. Both SPARC mRNA and protein were detected in human adipose tissue. Comparing adipocytes and vascular stroma, we found that SPARC expression was mainly associated with the adipocyte fraction. Consistent with this, SPARC transcript increased during differentiation of human primary preadipocytes. 3T3-L1 preadipocytes showed an increase in SPARC expression in differentiated cells but with biphasic expression during the process. After induction in committed cells, SPARC mRNA and protein levels declined as differentiation began and returned to elevated levels in fully differentiated adipocytes. DISCUSSION: SPARC expression correlated with adipose tissue hyperplasia and adipogenesis. Therefore, SPARC seems to play a role in adipose tissue physiology as it is involved in growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17135603     DOI: 10.1038/oby.2006.220

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  16 in total

1.  RNA-seq analysis of bovine intramuscular, subcutaneous and perirenal adipose tissues.

Authors:  Xihui Sheng; Hemin Ni; Yunhai Liu; Junya Li; Lupei Zhang; Yong Guo
Journal:  Mol Biol Rep       Date:  2014-01-08       Impact factor: 2.316

Review 2.  The bone-adipose axis in obesity and weight loss.

Authors:  J Gómez-Ambrosi; A Rodríguez; V Catalán; G Frühbeck
Journal:  Obes Surg       Date:  2008-06-19       Impact factor: 4.129

Review 3.  SPARC: a key player in the pathologies associated with obesity and diabetes.

Authors:  Katarina Kos; John P H Wilding
Journal:  Nat Rev Endocrinol       Date:  2010-03-02       Impact factor: 43.330

4.  Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression.

Authors:  Fiona C Mansergh; Timothy Wells; Carole Elford; Samuel L Evans; Mark J Perry; Martin J Evans; Bronwen A J Evans
Journal:  Physiol Genomics       Date:  2007-09-18       Impact factor: 3.107

5.  IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells.

Authors:  Jing Nie; Benny Chang; Dmitry O Traktuev; Jessica Sun; Keith March; Lawrence Chan; E Helene Sage; Renata Pasqualini; Wadih Arap; Mikhail G Kolonin
Journal:  Stem Cells       Date:  2008-06-26       Impact factor: 6.277

6.  Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults.

Authors:  Yeon Ji Lee; Yoon-Seok Heo; Hye Soon Park; Seoung Hee Lee; Seul Ki Lee; Yeon Jin Jang
Journal:  Obes Surg       Date:  2014-04       Impact factor: 4.129

7.  Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle.

Authors:  Louise H Jørgensen; Stine J Petersson; Jeeva Sellathurai; Ditte C Andersen; Susanne Thayssen; Dorte J Sant; Charlotte H Jensen; Henrik D Schrøder
Journal:  J Histochem Cytochem       Date:  2008-09-15       Impact factor: 2.479

8.  Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.

Authors:  Katrina Kos; Steve Wong; Bee Tan; Anders Gummesson; Margareta Jernas; Niclas Franck; David Kerrigan; Fredrik H Nystrom; Lena M S Carlsson; Harpal S Randeva; Jonathan H Pinkney; John P H Wilding
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

9.  SPARC functions as an inhibitor of adipogenesis.

Authors:  Jing Nie; E Helene Sage
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

10.  A role for SPARC in the moderation of human insulin secretion.

Authors:  Lorna W Harries; Laura J McCulloch; Janet E Holley; Thomas J Rawling; Hannah J Welters; Katarina Kos
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.